Literature DB >> 23180153

Expression patterns of MDA-9/syntenin during development of the mouse embryo.

Hyun Yong Jeon1, Swadesh K Das, Santanu Dasgupta, Luni Emdad, Devanand Sarkar, Sung-Hoon Kim, Seok-Geun Lee, Paul B Fisher.   

Abstract

Melanoma differentiation associated gene-9 (MDA-9)/syntenin is a PDZ domain-containing adaptor protein involved in multiple diverse cellular processes including organization of protein complexes in the plasma membrane, intracellular trafficking and cell surface targeting, synaptic transmission, and cancer metastasis. In the present study, we analyzed the expression pattern of MDA-9/syntenin during mouse development. MDA-9/syntenin was robustly expressed with tight regulation of its temporal and spatial expression during fetal development in the developing skin, spinal cord, heart, lung and liver, which are regulated by multiple signaling pathways in the process of organogenesis. Recent studies also indicate that MDA-9/syntenin is involved in the signaling pathways crucial during development such as Wnt, Notch and FGF. Taken together, these results suggest that MDA-9/syntenin may play a prominent role during normal mouse development in the context of cell proliferation as well as differentiation through modulating multiple signaling pathways as a crucial adaptor protein. Additionally, temporal regulation of MDA-9/syntenin expression may be required during specific stages and in specific tissues during development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180153      PMCID: PMC3605205          DOI: 10.1007/s10735-012-9468-1

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  38 in total

Review 1.  Getting under the skin of epidermal morphogenesis.

Authors:  Elaine Fuchs; Srikala Raghavan
Journal:  Nat Rev Genet       Date:  2002-03       Impact factor: 53.242

2.  Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.

Authors:  Maria Francesca Baietti; Zhe Zhang; Eva Mortier; Aurélie Melchior; Gisèle Degeest; Annelies Geeraerts; Ylva Ivarsson; Fabienne Depoortere; Christien Coomans; Elke Vermeiren; Pascale Zimmermann; Guido David
Journal:  Nat Cell Biol       Date:  2012-06-03       Impact factor: 28.824

Review 3.  Sizing up the heart: development redux in disease.

Authors:  Eric N Olson; Michael D Schneider
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

4.  Role of Unc51.1 and its binding partners in CNS axon outgrowth.

Authors:  Toshifumi Tomoda; Jee Hae Kim; Caixin Zhan; Mary E Hatten
Journal:  Genes Dev       Date:  2004-03-10       Impact factor: 11.361

Review 5.  The molecular basis of lung morphogenesis.

Authors:  D Warburton; M Schwarz; D Tefft; G Flores-Delgado; K D Anderson; W V Cardoso
Journal:  Mech Dev       Date:  2000-03-15       Impact factor: 1.882

6.  Schwannomin isoform-1 interacts with syntenin via PDZ domains.

Authors:  M Jannatipour; P Dion; S Khan; H Jindal; X Fan; J Laganière; A H Chishti; G A Rouleau
Journal:  J Biol Chem       Date:  2001-06-29       Impact factor: 5.157

7.  Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines.

Authors:  Tae Hyeon Koo; Jung-Joon Lee; Eun-Mi Kim; Kyu-Won Kim; Han Do Kim; Jeong-Hyung Lee
Journal:  Oncogene       Date:  2002-06-13       Impact factor: 9.867

8.  Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein.

Authors:  N Geijsen; I J Uings; C Pals; J Armstrong; M McKinnon; J A Raaijmakers; J W Lammers; L Koenderman; P J Coffer
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

9.  Different binding motifs in metabotropic glutamate receptor type 7b for filamin A, protein phosphatase 1C, protein interacting with protein kinase C (PICK) 1 and syntenin allow the formation of multimeric protein complexes.

Authors:  Ralf Enz; Cristina Croci
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

10.  The PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor subtypes. Analysis of PDZ binding motifs.

Authors:  Hélène Hirbec; Olga Perestenko; Atsushi Nishimune; Guido Meyer; Shigetada Nakanishi; Jeremy M Henley; Kumlesh K Dev
Journal:  J Biol Chem       Date:  2002-03-12       Impact factor: 5.157

View more
  6 in total

1.  Phosphoproteomics of Fibroblast Growth Factor 1 (FGF1) Signaling in Chondrocytes: Identifying the Signature of Inhibitory Response.

Authors:  Jessica R Chapman; Olga Katsara; Rachel Ruoff; David Morgenstern; Shruti Nayak; Claudio Basilico; Beatrix Ueberheide; Victoria Kolupaeva
Journal:  Mol Cell Proteomics       Date:  2017-03-15       Impact factor: 5.911

2.  Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.

Authors:  Nara Tae; Suhyun Lee; Okwha Kim; Juhee Park; Sunghun Na; Jeong-Hyung Lee
Journal:  Oncotarget       Date:  2017-06-13

3.  Syntenin-knock out reduces exosome turnover and viral transduction.

Authors:  Rudra Kashyap; Marielle Balzano; Benoit Lechat; Kathleen Lambaerts; Antonio Luis Egea-Jimenez; Frédérique Lembo; Joanna Fares; Sofie Meeussen; Sebastian Kügler; Anton Roebroek; Guido David; Pascale Zimmermann
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

Review 4.  MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.

Authors:  Swadesh K Das; Santanu Maji; Stephen L Wechman; Praveen Bhoopathi; Anjan K Pradhan; Sarmistha Talukdar; Devanand Sarkar; Joseph Landry; Chunqing Guo; Xiang-Yang Wang; Webster K Cavenee; Luni Emdad; Paul B Fisher
Journal:  Pharmacol Res       Date:  2020-02-13       Impact factor: 7.658

Review 5.  Targeting tumor invasion: the roles of MDA-9/Syntenin.

Authors:  Timothy P Kegelman; Swadesh K Das; Luni Emdad; Bin Hu; Mitchell E Menezes; Praveen Bhoopathi; Xiang-Yang Wang; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Ther Targets       Date:  2014-09-15       Impact factor: 6.902

6.  Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.

Authors:  Swadesh K Das; Chunqing Guo; Anjan K Pradhan; Praveen Bhoopathi; Sarmistha Talukdar; Xue-Ning Shen; Luni Emdad; Mark A Subler; Jolene J Windle; Devanand Sarkar; Xiang-Yang Wang; Paul B Fisher
Journal:  Oncotarget       Date:  2016-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.